[1]
|
Ries, L.A.G., Eisner, M.P., Kosary, C.L., et al. (2002) Cancer Statistics Review. National Cancer Institute, Bethesda.
|
[2]
|
Yost, K., Perkins, C., Cohen, R., Morris, C. and Wright, W. (2001) Socioeconomic Status and Breast Cancer Incidence in California for Different Race/Ethnic Groups. Cancer Causes & Control, 12, 703-711. https://doi.org/10.1023/A:1011240019516
|
[3]
|
Ganem, D. (1997) KSH CV and Kaposi’s Sarcoma: The End of the Beginning? Cell, 91, 157-160. https://doi.org/10.1016/S0092-8674(00)80398-0
|
[4]
|
Macsween, K.F. and Crawford, D.H. (2003) Epstein-Barr Virus-Recent Advances. Lancet Infectious Diseases, 3, 131-140.
https://doi.org/10.1016/S1473-3099(03)00543-7
|
[5]
|
Matsuoka, M. (2003) Human T-Cell Leukemia Virus Type I and Adult T-Cell Leukemia. Oncogene, 22, 5131-5140. https://doi.org/10.1038/sj.onc.1206551
|
[6]
|
Zur Hausen, H. (2000) Papillomaviruses Causing Cancer: Evasion from Host-Cell Control in Early Events in Carcinogenesis. Journal of the National Cancer Institute, 92, 690-698. https://doi.org/10.1093/jnci/92.9.690
|
[7]
|
Arbach, H., Viglasky, V., Lefeu, F., et al. (2006) Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol). Journal of Virology, 80, 845-853.
https://doi.org/10.1128/JVI.80.2.845-853.2006
|
[8]
|
Dalia, D., Mourah, S., Podgorniak, M., Joab, I., Radulescy, C., Elhassen, B. and Zohra, E. (2015) Research of Epstein-Barr Virus Genome and Quantification of Viral Load in Algerian Frozen Tissue of Breast Cancer. International Journal of Cancer Research, 11, 32-40. https://doi.org/10.3923/ijcr.2015.32.40
|
[9]
|
Rickinson, A.B. and Kieff, E. (1996) Epstein-Barr Virus. In: Fields, B.N., Knipe, D.M. and Howley, P.M., Eds., Fields Virology, Vol. 2, Lippincott-Raven, Philadelphia, 2397-2446.
|
[10]
|
Ferlay, J., Bray, F., Pisan, P., et al. (2004) GLOBOCAN 2002 Cancer Incidence. Mortality and Prevalence Worldwide IARC Cancer Base No. 5, Version 2.0, IARC Press, Lyon.
|
[11]
|
Bittner, J.J. (1942) The Milk-Influence of Breast Tumors in Mice. Science, 95, 462-463. https://doi.org/10.1126/science.95.2470.462
|
[12]
|
Bonnet, M., Guinebretiere, J.M., Kremmer, E., et al. (1999) Detection of Epstein-Barr Virus in Invasive Breast Cancers. Journal of the National Cancer Institute, 91, 1376-1381. https://doi.org/10.1093/jnci/91.16.1376
|
[13]
|
Bensaber, H.S. (2011) Distribution intratumorale mammaire des marqueurs Her2, PS2, MIB1 et des récepteurs hormonaux selon l’age et le grade SBR.
|
[14]
|
WHO (World Health Organization) (1990) International of Diseases for Oncology. 2nd Edition, World Health Organization, Geneva.
|
[15]
|
Sabin, L. and Wittekind, C. (1998) TNM Classification of Malignant Tumours. 5th Edition, John Wiley & Sons Inc., Hoboken.
|
[16]
|
Bloom, H.J. and Richardson, W.W. (1957) Histological Grading and Prognosis in Breast Cancer: A Study of 1409 Cases of Which 359 Have Been Followed for 15 Years. British Journal of Cancer, 11, 359-377. https://doi.org/10.1038/bjc.1957.43
|
[17]
|
Saiki, R.K., Bugawan, T.L., Horn, G.T., Mullis, K.B. and Erlich, H.A. (1986) Analysis of Enzymatically Amplified Beta-Globin and HLA-DQ Alpha DNA with Allele-Specific Oligonucleotide Probes. Nature, 324, 163-166.
https://doi.org/10.1038/324163a0
|
[18]
|
Gopal, M.R., Thomson, B.J., Fox, J., Tedder, R.S. and Honess, R.W. (1990) Detection by PCR of HHV-6 and EBV DNA in Blood and Oropharynx of Healthy Adults and HIV Seropositives. Lancet, 335, 1598-1599.
https://doi.org/10.1016/0140-6736(90)91433-B
|
[19]
|
Gaffey, M.J., Frierson, H.F., Mills, S.E., et al. (1993) Medullary Carcinoma of the Breast. Identification of Lymphocyte Subpopulations and Their Significance. Modern Pathology, 6, 721-728.
|
[20]
|
Grinstein, S., Preciado, M.V., Gattuso, P., et al. (2002) Demonstration of Epstein-Barr Virus in Carcinomas of Various Sites. Cancer Research, 62, 4876-4878.
|
[21]
|
Lespagnard, L., Cochaux, P., Larsimont, D., et al. (1995) Absence of Epstein-Barr Virus in Medullary Carcinoma of the Breast as Demonstrated by Immunophenotyping, in Situ Hybridization and Polymerase Chain Reaction. Journal of Clinical Pathology, 103, 449-452. https://doi.org/10.1093/ajcp/103.4.449
|
[22]
|
McCall, S.A., Lichy, J.H., Bijwaard, K.E., et al. (2001) Epstein-Barr Virus Detection in Ductal Carcinoma of the Breast. Journal of the National Cancer Institute, 93, 148-150. https://doi.org/10.1093/jnci/93.2.148
|
[23]
|
Preciado, M.V., Chabay, P.A., De Matteo, E.N., et al. (2005) Epstein-Barr Virus in Breast Carcinoma in Argentina. Archives of Pathology & Laboratory Medicine, 129, 377-381.
|
[24]
|
Serraino, D., Piselli, P. and Scognamiglio, P. (2001) Viral Infections and Cancer: Epidemio-Logical Aspects. Journal of Biological Regulators & Homeostatic Agents, 15, 224-228.
|
[25]
|
Huang, J., Chen, H., Hutt-Fletcher, L., Ambinder, R.F. and Hayward, S.D. (2003) Lytic Viral Replication as a Contributor to the Detection of Epstein-Barr Virus in Breast Cancer. Journal of Virology, 77, 13267-13274.
https://doi.org/10.1128/JVI.77.24.13267-13274.2003
|
[26]
|
Deshpande, C.G., Badve, S. and Kidwai, N. (2002) Lack of Expression of the Epstein-Barr Virus (EBV) Gene Products, EBERs, EBNA1, LMP1, and LMP2A, in Breast Cancer Cells. Laboratory Investigation, 82, 1193-1199.
https://doi.org/10.1097/01.LAB.0000029150.90532.24
|
[27]
|
Dadmanesh, F., Peterse, J.L. and Sapino, A. (2001) Lymphoepitheliomalike Carcinoma of the Breast: Lack of Evidence of Epstein-Barr Virus Infection. Histopathology, 38, 54-61. https://doi.org/10.1046/j.1365-2559.2001.01055.x
|
[28]
|
Glaser, S.L., Lin, R.J., Stewart, S.L., et al. (1997) Epstein-Barr Virus-Associated Hodgkin’s Disease: Epidemiologic Characteristics in International Data. International Journal of Cancer, 70, 375-382.
https://doi.org/10.1002/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T
|
[29]
|
Preciado, M.V. (2003) Lack of Evidence for an Association of Epstein-Barr Virus Infection with Breast Carcinoma—Another Point of View. Breast Cancer Research, 5, E6. https://doi.org/10.1186/bcr599
|
[30]
|
Chu, J.S., Chen, C.C. and Chang, K.J. (1998) In Situ Detection of Epstein-Barr Virus in Breast Cancer. Cancer Letters, 124, 53-57.
https://doi.org/10.1016/S0304-3835(97)00449-7
|
[31]
|
Labrecque, L.G., Barnes, D.M. and Fentiman, I.S. (1995) Epstein-Barr Virus in Epithelial Cell Tumors: A Breast Cancer Study. Cancer Research, 55, 39-45.
|
[32]
|
Chu, P.G., Chang, K.L. and Chen, Y.Y. (2001) No Significant Association of Epstein-Barr Virus Infection with Invasive Breast Carcinoma. Journal of Pathology, 159, 571-578.
|
[33]
|
Kieff, E. and Rickinson, A.B. (1996). Epstein-Barr Virus and Its Replication. In: Knipe, D.M., Howley, P.M., Griffin, D.E., Martin, M.A. and Lamb, R.A., Eds., Field’s Virology, Lippincott-Raven Press, Philadelphia, 2511-2573.
|
[34]
|
Fina, F., Romain, S., Ouafik, L., et al. (2001) Frequency and Genome Load of Epstein-Barr Virus in 509 Breast Cancers from Different Geographical Areas. British Journal of Cancer, 84, 783-790. https://doi.org/10.1054/bjoc.2000.1672
|
[35]
|
Kijima, Y., Hokita, S., Takao, S., et al. (2001) Epstein-Barr Virus Involvement Is Mainly Restricted to Lymphoepithelial Type of Gastric Carcinoma among Various Epithelial Neoplasms. Journal of Medical Virology, 64, 513-518.
https://doi.org/10.1002/jmv.1079
|
[36]
|
Xue, S.A., Lampert, I.A., Haldane, J.S., Bridger, J.E. and Griffin, B.E. (2003) Epstein-Barr Virus Gene Expression in Human Breast Cancer: Protagonist or Passenger? British Journal of Cancer, 89, 113-119. https://doi.org/10.1038/sj.bjc.6601027
|
[37]
|
Lin, J.H., Tsai, C.H., Chu, J.S., et al. (2007) Dysregulation of HER2/HER3 Signaling Axis in Epstein-Barr Virus-Infected Breast Carcinoma Cells. Journal of Virology, 81, 5705-5713. https://doi.org/10.1128/JVI.00076-07
|
[38]
|
Yu, D., Liu, B., Jin, T., Sun, D., Price, J.E., Singletary, S.E., et al. (1998) Over-Expression of Both p185c-erbB2 and p170mdr-1 Renders Breast Cancer Cells Highly Resistant to Taxol. Oncogene, 16, 2087-2094. https://doi.org/10.1038/sj.onc.1201729
|
[39]
|
Mazouni, C., Fina, F., Romain, S., Ouafik, L., Bonnier, P., et al. (2011) Epstein-Barr Virus as a Marker of Biological Aggressiveness in Breast Cancer. British Journal of Cancer, 104, 332-337. https://doi.org/10.1038/sj.bjc.6606048
|
[40]
|
Perrigoue, J.G., den Boon, J.A., Friedl, A., Newton, M.A., Ahlquist, P. and Sugden, B. (2005) Lack of Association between EBV and Breast Carcinoma. Cancer Epidemiology, Biomarkers & Prevention, 14, 809-814.
https://doi.org/10.1158/1055-9965.EPI-04-0763
|
[41]
|
Perkins, R.S., Sahm, K., Marando, C., Dickson-Witmer, D., Pahnke, G.R., Mitchell, M., Petrelli, N.J., Berkowitz, I.M., Soteropoulos, P., Aris, V.M., Dunn, S.P. and Krueger, L.J. (2006) Analysis of Epstein-Barr Virus Reservoirs in Paired Blood and Breast Cancer Primary Biopsy Specimens by Real Time PCR. Breast Cancer Research, 8, R70. https://doi.org/10.1186/bcr1627
|